BINV.ST Gross Margin

The Gross Margin of BioInvent International AB (BINV.ST) is 42.37%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

BINV.ST Gross Margin - Historical Value

Date	Value
2024-12-31	42.37%

BINV.ST Gross Margin - Peers Comparison

Ticker	Name	Value
DMYD B.ST	Diamyd Medical AB	-10161.54%
MAB.WA	Mabion SA	59.62%
MDXH.BR	MDxHealth SA	51.74%
SANION.ST	Saniona AB	85.03%
SCLP.L	Scancell Holdings PLC	94.95%
EGTX.ST	Egetis Therapeutics AB (publ)	74.84%
IVACC.ST	Intervacc AB	-29.92%
VITR.ST	Vitrolife AB	59.27%
FARN.L	Faron Pharmaceuticals Oy	95.19%
HPHA.DE	Heidelberg Pharma AG	74.01%
OSE.PA	OSE Immunotherapeutics SA	100.00%
ALBPS.PA	Biophytis SA	7775.20%
BGBIO.OL	Bergenbio ASA	100.00%
MDG1.DE	Medigene AG	72.77%
BVXP.L	Bioventix PLC	93.20%
OXUR.BR	Oxurion NV	-1333.33%
POXEL.PA	Poxel SA	0.05%
TILS.L	Tiziana Life Sciences PLC	63.16%
VSC.DE	4Sc AG	97.20%
XBRANE.ST	Xbrane Biopharma AB	90.83%
XSPRAY.ST	XSpray Pharma AB (publ)	2539.90%
AEGIR.ST	Aegirbio AB	47.83%
BIOA B.ST	BioArctic AB	89.51%
HNSA.ST	Hansa Biopharma AB	51.23%
PROB.ST	Probi AB	35.08%
ALSEN.PA	Sensorion SA	7775.20%
BIOG B.ST	Biogaia AB	72.45%
BLR.WA	Blirt SA	77.13%
ETX.L	E-Therapeutics PLC	100.00%
ORY.MC	Oryzon Genomics SA	-4700.00%
SOBI.ST	Swedish Orphan Biovitrum AB (publ)	78.03%
ABVX.PA	Abivax SA	-19700.00%
ALQGC.PA	Quantum Genomics SA	-14205.07%
BONEX.ST	Bonesupport Holding AB	92.60%
GNFT.PA	Genfit SA	97.11%
NANOV.OL	Nordic Nanovector ASA	7775.20%